Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis

被引:0
|
作者
Reiki Nishimura
Tomofumi Osako
Yasuhiro Okumura
Mitsuhiro Hayashi
Nobuyuki Arima
机构
[1] Kumamoto City Hospital,Department of Breast and Endocrine Surgery
[2] Kumamoto City Hospital,Department of Clinical Pathology
来源
Breast Cancer | 2010年 / 17卷
关键词
Breast cancer; Ki-67; Neoadjuvant chemotherapy; Predictive factor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:269 / 275
页数:6
相关论文
共 50 条
  • [21] Prognostic significance of reduction rate of Ki-67 after neoadjuvant chemotherapy in breast cancer patients with non-pCR.
    Matsubara, Nobuaki
    Mukai, Hirofumi
    Naito, Yoichi
    Hosono, Ako
    Itoh, Kuniaki
    Fujii, Satoshi
    Yoneyama, Kimiyasu
    Wada, Noriaki
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [22] The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer
    Jones, Robin L.
    Salter, Janine
    A'Hern, Roger
    Nerurkar, Ash
    Parton, Marina
    Reis-Filho, Jorge S.
    Smith, Ian E.
    Dowsett, Mitchell
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 116 (01) : 53 - 68
  • [23] The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer
    Robin L. Jones
    Janine Salter
    Roger A’Hern
    Ash Nerurkar
    Marina Parton
    Jorge S. Reis-Filho
    Ian E. Smith
    Mitchell Dowsett
    Breast Cancer Research and Treatment, 2009, 116 : 53 - 68
  • [24] Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancer
    Tanei, T.
    Shimomura, A.
    Shimazu, K.
    Nakayama, T.
    Kim, S. J.
    Iwamoto, T.
    Tamaki, Y.
    Noguchi, S.
    EJSO, 2011, 37 (02): : 155 - 161
  • [25] Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy
    Acs, Balazs
    Zambo, Veronika
    Vizkeleti, Laura
    Szazs, A. Marcell
    Madaras, Lilla
    Szentmartoni, Gyongyver
    Tokes, Timea
    Molnar, Bela A.
    Molnar, Istvan Artur
    Vari-Kakas, Stefan
    Kulka, Janina
    Tokes, Anna-Maria
    DIAGNOSTIC PATHOLOGY, 2017, 12 : 1 - 12
  • [26] Ki-67 CAN BE USED AS A PREDICTIVE FACTOR FOR THE EFFECTIVENESS OF NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS
    Kozar, N.
    Sikosek, N. Cas
    Arko, D.
    Ravnik, M.
    Takac, I.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 115 - 115
  • [27] Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy
    Balázs Ács
    Veronika Zámbó
    Laura Vízkeleti
    A. Marcell Szász
    Lilla Madaras
    Gyöngyvér Szentmártoni
    Tímea Tőkés
    Béla Á. Molnár
    István Artúr Molnár
    Stefan Vári-Kakas
    Janina Kulka
    Anna-Mária Tőkés
    Diagnostic Pathology, 12
  • [28] KI-67 CAN BE USED AS A PREDICTIVE FACTOR FOR THE EFFECTIVENESS OF NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS
    Kozar, N.
    Sikosek, N. Cas
    Arko, D.
    Ravnik, M.
    Takac, I.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 635 - 635
  • [29] Can Ki-67 Play a Role in Prediction of Breast Cancer Patients' Response to Neoadjuvant Chemotherapy?
    Ingolf, Juhasz-Boss
    Russalina, Mavrova
    Simona, Moga
    Julia, Radosa
    Gilda, Schmidt
    Bohle, Rainer M.
    Andrea, Hasenfus
    Erich, Solomayer
    Daniel, Herr
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [30] Prognostic significance of Ki-67 index value at the primary breast tumor in recurrent breast cancer
    Nishimura, Reiki
    Osako, Tomofumi
    Nishiyama, Yasuyuki
    Tashima, Rumiko
    Nakano, Masahiro
    Fujisue, Mamiko
    Toyozumi, Yasuo
    Arima, Nobuyuki
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (06) : 1062 - 1068